Detailed View
ABUS - Arbutus Biopharma Corporation
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
656,020,928
Adj EBIT (TTM)
154,504,000
Enterprise Value
636,849,928
Last Price
4.28
Earnings Yield
24.26%
Return on Capital
57.08%
Capital
270,661,000
1Y Price Chart
Last Price: $4.28
1Y Change: -6.55%
As of 2026-10-29 | 1Y Change: -6.55%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 1,014,000 | -5,964,000 |
| 2026-03-31 | 10-Q | 2026 | 179,126,000 | 168,908,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 1,051,000 | -5,290,000 |
| 2025-09-30 | 10-Q | 2025 | 529,000 | -8,659,000 |
| 2025-06-30 | 10-Q | 2025 | 10,739,000 | 1,488,000 |
| 2025-03-31 | 10-Q | 2025 | 1,764,000 | -25,699,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 1,574,000 | -13,933,000 |
| 2024-09-30 | 10-Q | 2024 | 1,339,000 | -21,440,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.